Hosted on MSN10mon
New analysis shows tirzepatide consistently reduces body weight regardless of body mass index (BMI) before treatment3% in SURMOUNT-2, and up to 78% vs. 4% in SURMOUNT-3. In SURMOUNT-4, during the 36-week open-label tirzepatide treatment, the mean body weight reduction was 21%. After this lead-in period ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback